-
1 Comment
Tactile Systems Technology, Inc is currently in a long term uptrend where the price is trading 3.1% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.6.
Tactile Systems Technology, Inc's total revenue rose by 3.8% to $59M since the same quarter in the previous year.
Its net income has increased by 182.8% to $12M since the same quarter in the previous year.
Finally, its free cash flow grew by 413.3% to $5M since the same quarter in the previous year.
Based on the above factors, Tactile Systems Technology, Inc gets an overall score of 5/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
Sector | Healthcare |
Industry | Medical Devices |
ISIN | US87357P1003 |
Market Cap | 300M |
---|---|
PE Ratio | 19.52 |
Target Price | 70 |
Beta | 1.21 |
Dividend Yield | None |
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3L3.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025